Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC)

Published:2021-01-08 Issue:1 Volume:100 Page:e23875
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

He Canfeng,Lin Ruiting,Zhang Jing,Sun Lingling,Lin Jietao,Lin Lizhu

Funder

Hospital-made Preparation Development Project from the First Affiliated Hospital of Guangzhou University of Chinese Medicine

National Administration of Traditional Chinese Medicine : 2019 Project of building evidence based practice capacity for TCM

National Natural Science Foundation of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Management of egfr tki-induced dermatologic adverse events;Melosky;Curr Oncol,2015

2. Clinical features and treatment of epidermal growth factor inhibitor-related late-phase papulopustular rash;Tohyama;J Dermatol,2020

3. Management of nonhematologic toxicities associated with different EGFR-TKIs in advanced NSCLC: a comparison analysis;Passaro;Clin Lung Cancer,2014

4. Association between subjective evaluation of skin toxicities and quality of life in patients with lung cancer undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a pilot study for developing skin toxicity assessment;Hirayama;Open J Nurs,2019

5. Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis;Petrelli;Br J Dermatol,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in NSCLC;American Journal of Clinical Oncology;2024-02-20